| Product Code: ETC066682 | Publication Date: Aug 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Mexico Infectious Disease Point-of-care Testing Market was estimated at USD 98 Million in 2025 and is projected to reach USD 113 Million by 2032, growing at a CAGR of 2.1% from 2026 to 2032. This growth trajectory is primarily driven by the increasing demand for rapid and decentralized testing solutions, particularly in light of recent health crises. Furthermore, the Mexican government's efforts to enhance healthcare accessibility in underserved areas bolster the urgency for effective point-of-care testing.
This graph highlights how the Mexico Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -4.0% | Increasing industrial infrastructure investments |
| 2022 | 5.6% | Expansion of transportation and logistics networks |
| 2023 | 4.8% | Increasing industrial infrastructure investments |
| 2024 | 3.8% | Expansion of transportation and logistics networks |
| 2025 | 1.9% | Increasing industrial automation investments |
| 2026 | 1.0% | Rapid growth in telecom and data center sectors |
| 2027 | 2.1% | Rising electricity demand across industries |
| 2028 | 2.7% | Increasing industrial automation investments |
| 2029 | 2.4% | Rapid growth in telecom and data center sectors |
| 2030 | 2.9% | Government infrastructure modernization initiatives |
| 2031 | 3.0% | Rapid growth in telecom and data center sectors |
| 2032 | 2.9% | Increasing industrial automation investments |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The most significant force currently shaping the Mexico Infectious Disease Point-of-care Testing Market is the pressing need for swift diagnostic solutions. The demand for immediate, on-the-spot testing has surged as outbreaks become increasingly common, highlighting the limitations of traditional testing methods.
Government initiatives also play a pivotal role in this market, focusing on the development and deployment of point-of-care testing facilities. These efforts are designed to facilitate rapid diagnosis and treatment, ultimately leading to better management of infectious disease outbreaks across the nation.
Despite its promising growth potential, the Mexico Infectious Disease Point-of-care Testing Market faces several constraints that impede its progress. Access to testing facilities remains limited, particularly in remote and rural areas, leading to delays in diagnosis and treatment. Furthermore, inadequate infrastructure and logistical hurdles exacerbate the difficulties associated with distributing point-of-care testing devices. As a result, fostering collaborations among healthcare providers, government entities, and technology firms is crucial to overcoming these obstacles and ensuring comprehensive testing availability throughout the country.
Current trends in the Mexico Infectious Disease Point-of-care Testing Market indicate a growing preference for integrated diagnostic platforms that facilitate multi-disease testing. Moreover, the adaptation of telehealth services is complementing point-of-care testing, allowing healthcare providers to interpret results in real time. Advances in digital health and artificial intelligence are also being harnessed to improve the accuracy and speed of diagnosis, further reshaping the market landscape.
Significant growth opportunities exist within the Mexico Infectious Disease Point-of-care Testing Market, especially in rural regions. Enhanced government funding and initiatives aimed at expanding healthcare infrastructure are creating an environment ripe for investment. Additionally, innovations in testing technology present avenues for differentiation, allowing manufacturers and providers to capture a larger share of this emerging market. The demand for localized and accessible healthcare solutions will continue to drive investments in this sector.
The Mexican government has implemented a series of public health policies that prioritize early detection and rapid response to infectious diseases. These initiatives aim to enhance accessibility to point-of-care testing facilities, particularly in remote areas, thus facilitating timely diagnosis and treatment. In addition, the government is actively collaborating with healthcare stakeholders to strengthen the infrastructure necessary for widespread testing, ensuring that the population is better equipped to manage outbreaks.
Looking ahead to 2026-2032, the Mexico Infectious Disease Point-of-care Testing Market is positioned for steady growth. The ongoing emphasis on rapid diagnostic capabilities, coupled with governmental support for healthcare improvements, is likely to sustain market momentum. As technological advancements continue to emerge, the market will increasingly adapt to incorporate new testing modalities, ensuring that the healthcare system can respond effectively to future infectious disease challenges.
Recent developments in the Mexico Infectious Disease Point-of-care Testing Market highlight a surge in partnerships aimed at enhancing testing capabilities. Innovations in testing technology are being reported, focusing on increasing the speed and reliability of results. Additionally, there have been initiatives from various sectors to improve logistics and distribution networks for testing devices, addressing existing infrastructure challenges.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Infectious Disease Point-of-care Testing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Mexico Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Mexico Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Mexico Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Mexico |
4.2.2 Growing awareness about the benefits of point-of-care testing for infectious diseases |
4.2.3 Government initiatives to improve healthcare infrastructure and accessibility |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Mexico |
4.3.2 Lack of skilled healthcare professionals for conducting point-of-care testing |
4.3.3 Stringent regulatory requirements for approval of point-of-care testing products |
5 Mexico Infectious Disease Point-of-care Testing Market Trends |
6 Mexico Infectious Disease Point-of-care Testing Market, By Types |
6.1 Mexico Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Mexico Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Mexico Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Mexico Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Mexico Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Mexico Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Mexico Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Mexico Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Adoption rate of point-of-care testing technologies in healthcare facilities |
8.2 Percentage of infectious disease cases diagnosed using point-of-care testing |
8.3 Number of training programs conducted to educate healthcare professionals on point-of-care testing techniques |
9 Mexico Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Mexico Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Mexico Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Mexico Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Mexico Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here